Professor Steven Skaggs designed a type font Maxular

In 2015-16, Professor Steven Skaggs designed a type font specifically for people with macular degeneration, a condition that slowly destroys the macula, the part of the retina responsible for visual detail. People with macular degeneration have an increasingly difficult time reading. His typeface, Maxular Rx, is the first font ever designed specifically to counter the effects of macular degeneration. As reported in University of Louisville Magazine ("Type Driven," Winter-Spring issue, 2017), Maxular was selected to be part of an international study headed by Dr. Gordon Legge of University of Minnesota testing the readability, for those with the condition, of various typefaces. The clinical trials concluded this winter and Maxular proved to be a huge success. Maxular Rx led all typefaces in size acuity, measuring how small it could be read, and it was runner-up in reading speed at any size. Work now continues on introducing more weights of Maxular Rx. The trials suggest that the features that make Maxular readable to people with macular degeneration also promise to make Maxular extremely legible in a variety of circumstances for people with normal vision. To that end, Maxular is now being adapted as an international character set with a large variety of weights, with accompanying italic, for general use. The type publisher Delve Fonts of Berkeley, California ( is expected to release Maxular to the public in the summer of 2018.